The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Phenotypic Study in 40 Patients With Dysferlin Gene Mutations: High Frequency of Atypical Phenotypes
Abstract
OBJECTIVE: To describe the phenotypic spectrum of dysferlin (DYSF) gene mutations (which cause dysferlinopathies, autosomal recessive muscular dystrophies) in patients with a dysferlin protein deficiency. DESIGN: Clinical, biological, and pathological data from 40 patients were reviewed. The diagnosis of dysferlinopathy was based on the absence or strong reduction of dysferlin in muscle, and confirmed by mutational screening of the DYSF gene. SETTING: Two French neuromuscular diseases centers (in Paris and Marseilles). RESULTS: Two main dysferlinopathy phenotypes are well recognized: Miyoshi myopathy and limb-girdle muscular dystrophy type 2B. Typical Miyoshi myopathy and limb-girdle muscular dystrophy type 2B were found in 20 (50%) patients only. Unusual phenotypes included a mixed phenotype, referred to as "proximodistal," combining distal and proximal onset in 14 (35%) patients, pseudometabolic myopathy in 4 (10%), and asymptomatic hyperCKemia (an increased serum creatine kinase level) in 2 (5%). The disease may worsen rapidly, and 10 (25%) patients were initially misdiagnosed as having polymyositis. We suggest a relationship between proximodistal phenotype, inflammation, and severity. CONCLUSION: In addition to typical Miyoshi myopathy and limb-girdle muscular dystrophy type 2B, dysferlinopathies are a clinically heterogeneous group of disorders ranging from asymptomatism to severe functional disability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, J., Aoki, M., Illa, I., Wu, C., Fardeau, M., Angelini, C., Serrano, C., Urtizberea, J. A., Hentati, F., Hamida, M. B., et al. (1998) · Nature Genetics · doi:10.1038/1682 · Cited by 924
Self-citationBashir, R., Britton, S., Strachan, T., Keers, S., Vafiadaki, E., Lako, M., Richard, I., Marchand, S., Bourg, N., Argov, Z., et al. (1998) · Nature Genetics · doi:10.1038/1689 · Cited by 688
Dysferlin is a Plasma Membrane Protein and is Expressed Early in Human Development
Anderson, L. V. B., Davison, K., Moss, J. A., Young, C., Cullen, M. J., Walsh, J., Johnson, M. A., Bashir, R., Britton, S., Keers, S., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.855 · Cited by 302
Illa, I., Serrano-Munuera, C., Gallardo, E., Lasa, A., Rojas-Garc�a, R., Palmer, J., Gallano, P., Baiget, M., Matsuda, C., & Brown, R. H. (2001) · Annals of Neurology · doi:10.1002/1531-8249(200101)49:1<130::aid-ana22>3.0.co;2-0 · Cited by 278
Weiler, T., Bashir, R., Anderson, L. V. B., Davison, K., Moss, J. A., Britton, S., Nylen, E., Keers, S., Vafiadaki, E., Greenberg, C. R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.871 · Cited by 184
Anderson, L. V. B., Harrison, R. M., Pogue, R., Vafiadaki, E., Pollitt, C., Davison, K., Moss, J. A., Keers, S., Pyle, A., Shaw, P. J., et al. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(00)00143-7 · Cited by 167
Limb‐girdle muscular dystrophies – from genetics to molecular pathology
Laval, S. H., & Bushby, K. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00555.x · Cited by 153
Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy
Aoki, M., Liu, J., Richard, I., Bashir, R., Britton, S., Keers, S. M., Oeltjen, J., Brown, H. E. V., Marchand, S., Bourg, N., et al. (2001) · Neurology · doi:10.1212/wnl.57.2.271 · Cited by 150
Self-citationUltrastructural changes in dysferlinopathy support defective membrane repair mechanism
Cenacchi, G., Fanin, M., Giorgi, L. B., & Angelini, C. I. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.018978 · Cited by 137
Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies
Nguyen, K., Bassez, G., Bernard, R., Krahn, M., Labelle, V., Figarella-Branger, D. F., Pouget, J., Hammouda, E. H., Béroud, C., Urtizberea, J. A., et al. (2005) · Human Mutation · doi:10.1002/humu.9355 · Cited by 123
Self-citation
Cited by
Evidence-based path to newborn screening for Duchenne muscular dystrophy
Mendell, J. R., Shilling, C., Leslie, N. D., Flanigan, K. M., al‐Dahhak, R., Gastier‐Foster, J., Kneile, K., Dunn, D. M., Duval, B., Aoyagi, A., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23528 · Cited by 813
Membrane Repair: Mechanisms and Pathophysiology
Cooper, S. T., & McNeil, P. L. (2015) · Physiological Reviews · doi:10.1152/physrev.00037.2014 · Cited by 386
Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer
Lostal, W., Bartoli, M., Bourg, N., Roudaut, C., Bentaïb, A., Miyake, K., Guerchet, N., Fougerousse, F., McNeil, P., & Richard, I. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq065 · Cited by 173
AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models
Sondergaard, P. C., Griffin, D. A., Pozsgai, E. R., Johnson, R. W., Grose, W. E., Heller, K. N., Shontz, K. M., Montgomery, C. L., Liu, J., Clark, K. R., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.172 · Cited by 99
“Although dysferlinopathies are slowly progressing disorders, approximately one-third of patients become wheelchair-dependent within 15 years of disease onset.(7,10) There is no cure for these diseases and limited treatment options are available.”
BackgroundTarnopolsky, M. A. (2016) · Continuum · doi:10.1212/con.0000000000000403 · Cited by 61
Metadata
- Authors
- Nguyen, K., Bassez, G., Krahn, M., Bernard, R., Laforêt, P., Labelle, V., Urtizberea, J. A., Figarella-Branger, D., Romero, N., Attarian, S., Leturcq, F., Pouget, J., Lévy, N., & Eymard, B.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2007-08-01
- Volume
- 64
- Issue
- 8
- Pages
- 1176
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2099194855
- Cited by
- 271
- References
- 18
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenotypic Study in 40 Patients With Dysferlin Gene Mutations: High Frequency of Atypical Phenotypes. https://app.cochat.ai/papers/10.1001/archneur.64.8.1176
- The paper
- Nguyen, K., Bassez, G., Krahn, M., Bernard, R., Laforêt, P., Labelle, V., Urtizberea, J. A., Figarella-Branger, D., Romero, N., Attarian, S., Leturcq, F., Pouget, J., Lévy, N., & Eymard, B. (2007). Phenotypic Study in 40 Patients With Dysferlin Gene Mutations: High Frequency of Atypical Phenotypes. Archives of Neurology. https://doi.org/10.1001/archneur.64.8.1176
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.